About Nandi Life Sciences
Once we have decided that something is the right thing to do, we are committeed to doing it for our patients, even if it is the hard thing to do.
We deliver exceptional patient and physician experiences with lasting outcomes. We effectively partner with the medical community to deliver sustainable impact at scale.
We start by understanding an innovation from a scientific founder’s perspective and work with them to persuade others to believe in, and invest in, innovative ideas.
We navigate the scientific and commercial domains with equal fluency and confidence. While we believe in the power of platforms, and we see value in partnerships to accelerate outcomes.
We use our platform and global network to profile and enable the work of our aspiring scientific founders. We raise awareness of, and advocate for, investment in rare diseases.
Our evidence-based approach to all commercial decision making means we can confidently forge ahead or make the tough calls when needed.
Our Home at The Texas Medical Center
The Texas Medical Center (TMC) is the largest medical complex in the world. TMC is at the forefront of advancing life sciences as the 8th largest business district in the US with 21 hospitals, generating $35B GDP. MD Anderson Cancer Center is the number one cancer research center in the US. With over 10M patients a year, it is the ideal location for proof-of-concept oncology and rare disease trials. TMC cancer researchers are supported by the $6B Cancer Prevention Institute of Texas fund (CPRIT), the second largest medical research fund in the US, only surpassed by the National Institutes of Health (NIH). Within this ecosystem, Nandi is working with scientists from MD Anderson Cancer Center, Rice University, Baylor College of Medicine, University of Texas (UT) Houston and UT Southwestern to build a pipeline of oncology and rare disease biotechs.